PHP542 Evaluation of Controversies in Drug Literature
|Coordinator/Primary Instructor||Dr. Lin|
|Catalog Description||Through critical review of literature, controversies in drug therapy and drug-associated illness will be evaluated to improve students’ knowledge and analytical skills.|
|Estimated Enrollment||30 (Preference will be given to P3 students.)|
Detailed Course Description
Drug-induced diseases (or adverse drug reactions - ADRs) is one of the leading causes of morbidity/mortality in health care. The use of increased number of drugs, as well as drug combinations, leads to more opportunity for ADRs to occur, as a result of additive effects of or drug interactions between concomitant medications. Pharmacists need a solid understanding of the frequency & mechanisms by which drug-induced disease occurs to minimize/prevent ADRs as they pertain to commonly used and/or high risk medications. The recognition of rare & unexpected ADRs is also important.
The first portion of this course is designed to teach students with how to identify, scrutinize, and utilize the information from the medical literature. Development of these skills will provide students with the ability to evaluate validity of existing literature in the area of drug-induced disease. It will also allow the successful student to stay abreast of therapeutic advances not found in textbooks.
The second portion of this course focuses on special topics in drug-induced disease.
Class activities: There are several assignments and/or in-class activities in which you will be required to participate. If you are not present, you cannot receive credit. Past examples include: MedWatch reporting, clinical drug consult, journal article presentations.
Examinations: Two exams will be given during the semester. Exams are not cumulative and will cover lecture material noted in the syllabus. Exam questions will be taken from the material covered in didactic lectures, assigned readings & journal club articles. Students are responsible for attending each examination.
Grading format (subject to change):